摘要
非抗发炎药物(NSAIDs steroidal prescribed for the commonly)是治疗疼痛,炎症和发烧的药物。他们通常耐受性良好的健康人,但患者的危险因素(高龄、肾功能损害,心脏衰竭,肝脏疾病,并发药物与抗高血压药物)、非甾体类抗炎药可引起严重的肾功能的不良影响。它们包括水钠潴留、水肿、心力衰竭、高血压、低钠血症、高钾血症恶化、急性肾损伤、慢性肾脏病、肾乳头坏死和急性间质性肾炎。这些不良反应多数是由于前列腺素合成的抑制作用,它们的剂量和时间依赖性。急性肾损伤的形式是短暂的,往往是可逆的,停药后。在一些患者中长期应用非甾体抗炎药可能引起慢性肾脏病。建议患者应该有预防性的策略,包括使用“最低有效剂量的非甾体类抗炎药”为“短”,监测肾功能、体液潴留、电解质异常。服用降压药物的患者应监测高血压,并应调整降压药物的剂量,如果需要的话。一般来说,非甾体类抗炎药和血管紧张素转换酶抑制剂的组合应避免。其他的一些预防措施,饮食限盐,使用外用非甾体抗炎药/非药物疗法和治疗高血压的钙通道阻滞剂的使用。
关键词: 非甾体类抗炎药,不良反应、肾、高血压、急性肾损伤、慢性肾脏病、急性间质性肾炎
Current Medicinal Chemistry
Title:Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs
Volume: 23 Issue: 19
Author(s): Sonja Vučković, Katarina Savić Vujović, Dragana Srebro, Branislava Medić, Tatjana Ilic-Mostic
Affiliation:
关键词: 非甾体类抗炎药,不良反应、肾、高血压、急性肾损伤、慢性肾脏病、急性间质性肾炎
摘要: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for the treatment of pain, inflamation and fever. They are usually well tolerated in healthy persons, but in patients with risk factors (advanced age, renal impairment, heart failure, liver disease, concurrent medications with antihypertensive drugs), NSAIDs can induce serious renal adverse effects. They include sodium and water retention with edema, worsening of heart failure, hypertension, hyponatremia, hyperkalemia, acute kidney injury, chronic kidney disease, renal papillary necrosis and acute interstitial nephritis. The majority of these adverse effects are due to the inhibition of prostaglandins synthesis and they are dose and duration-dependent. Acute forms of kidney injuries are transient and often reversible upon drug withdrawal. Chronic use of NSAIDs in some patients may result in chronic kidney disease. It is recommended that patients at risk should have preventative strategies in place, including the use of the “lowest effective dose” of NSAID for the “shortest possible time” and monitoring renal function, fluid retention and electrolyte abnormalities. Patients who are taking antihypertensive medications should be monitored for high blood pressure and the doses of antihypertensive medications should be adjusted if needed. In general, the combination of NSAIDs and angiotensin inhibitors should be avoided. Some other preventive measures are dietary salt restriction, use of topical NSAIDs/non-pharmacological therapies and use of calcium channel blockers for treating hypertension.
Export Options
About this article
Cite this article as:
Sonja Vučković, Katarina Savić Vujović, Dragana Srebro, Branislava Medić, Tatjana Ilic-Mostic , Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs, Current Medicinal Chemistry 2016; 23 (19) . https://dx.doi.org/10.2174/0929867323666160210125920
DOI https://dx.doi.org/10.2174/0929867323666160210125920 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design Surgical Ventricular Restoration to Reverse Left Ventricular Remodeling
Current Cardiology Reviews Cardiovascular Effects of the Phytoestrogen Genistein
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Combinatorial Therapies for Cardiac Regeneration
Recent Patents on Regenerative Medicine Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Current Vascular Pharmacology Synthesis and Evaluation of Compounds Containing 4-arylpiperazinyl Moieties Linked to a 2-(pyridin-3-yl)-1H-benzimidazole as p38 MAP Kinase Inhibitors
Letters in Drug Design & Discovery The Role of An Experimental Model of Atherosclerosis: apoE-knockout Mice in Developing New Drugs against Atherogenesis
Current Pharmaceutical Biotechnology Are Circulating Monocytes as Microglia Orthologues Appropriate Biomarker Targets for Neuronal Diseases? (Supplementry Table)
Central Nervous System Agents in Medicinal Chemistry An insight into the Interaction between Clopidogrel and Proton Pump Inhibitors
Current Drug Metabolism Normal Ventricular Functional Reference Parameters on Magnetic Resonance Imaging in Healthy Children
Current Medical Imaging Recent Valves used for Transluminal Implantation in Patients with Aortic Valve Stenosis
Recent Patents on Cardiovascular Drug Discovery Soy Isoflavones and Cardiovascular Disease Epidemiological, Clinical and -Omics Perspectives
Current Pharmaceutical Biotechnology Main Anti-tumor Angiogenesis Agents Isolated From Chinese Herbal Medicines
Mini-Reviews in Medicinal Chemistry Prevention of Sudden Cardiac Death in Hemodialysis Patients
Cardiovascular & Hematological Disorders-Drug Targets Prevention of Left Ventricular Remodelling after Acute Myocardial Infarction: An Update
Recent Patents on Cardiovascular Drug Discovery Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials
CNS & Neurological Disorders - Drug Targets Protrhombotic Effects of Contraceptives
Current Pharmaceutical Design Potential Therapeutic Applications of Metal Compounds Directed Towards Hypoxic Tissues
Current Medicinal Chemistry C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
Current Pharmaceutical Design Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design